Defining the Communication between Agonist and Coactivator Binding in the Retinoid X Receptor α Ligand Binding DomainLeeAnn J. Boerma, Matthew B. Renfrow, Patrick R. Griffin et al.|Journal of Biological Chemistry|2013Cited by 52
Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary CancersVenkatram R. Atigadda, Donald D. Muccio, Natalia Y. Kedishvili et al.|Journal of Medicinal Chemistry|2015Cited by 28
Structure, Energetics, and Dynamics of Binding Coactivator Peptide to the Human Retinoid X Receptor α Ligand Binding Domain Complex with 9-<i>cis</i>-Retinoic AcidGang Xia, Donald D. Muccio, Matthew B. Renfrow et al.|Biochemistry|2010Cited by 24
Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and preventionAnil Desphande, Donald D. Muccio, Clinton J. Grubbs et al.|Bioorganic & Medicinal Chemistry|2013Cited by 22
Methyl Substitution of a Rexinoid Agonist Improves Potency and Reveals Site of Lipid ToxicityVenkatram R. Atigadda, Donald D. Muccio, Clinton J. Grubbs et al.|Journal of Medicinal Chemistry|2014Cited by 21